- 4
- 2
- 2
Antonija HANZEK
8
Documents
Presentation
Antonija HANŽEK is a medical biochemist with interests in tumor biomarkers, innovations in gynecological cancers, and neuro-oncology . Currently working as a scientist on epitranscriptomic analysis for the diagnosis and treatment of gliomas.
Postdoctoral researcher at the Institute of Functional Genomics (IGF); INSERM U1191-CNRS UMR 5203; *Physiology and Cancer* Department - the Duffau/Hugnot team: *Brain plasticity, stem cells and diffuse low-grade gliomas*.
Antonija HANŽEK est biochimiste médical avec interests aux biomarqueurs tumoraux, aux innovations dans le cancers gynécologiques et en neuro-oncologie. Travaille actuellement en tant que scientifique sur l'analyse épitranscriptomique pour le diagnostic et le traitement des gliomes.
Chercheuse postdoctorale à l'Institut de Génomique Fonctionnelle (IGF) ; INSERM U1191- CNRS UMR 5203 ; Département *Physiologie et Cancer* - l'équipe Duffau/Hugnot: *Plasticité cérébrale, cellules souches et gliomes diffus de bas grade* .
Publications
- 5
- 5
- 4
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 8
- 5
- 1
|
Extracellular urinary microRNAs as non‑invasive biomarkers of endometrial and ovarian cancerJournal of Cancer Research and Clinical Oncology, 2023, pp.452. ⟨10.1007/s00432-023-04675-5⟩
Journal articles
hal-04061475v1
|
|
Identification and characterization of aptamers targeting ovarian cancer biomarker human epididymis protein 4 for the application in urineCancers, 2023, 15 (2), pp.452. ⟨10.3390/cancers15020452⟩
Journal articles
hal-03935282v1
|
|
Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical UtilityInternational Journal of Molecular Sciences, 2022, 23 (21), pp.13582. ⟨10.3390/ijms232113582⟩
Journal articles
hal-03868300v1
|
|
High-specificity nucleic acid aptamers for detection of ovarian cancer protein biomarkers: Application in diagnosticsAptamers, 2021, 5, pp.7-14
Journal articles
hal-03581895v1
|
Aptamers as diagnostic tools for the detection of Human Epididymis protein 4 (HE4), clinical biomarker of ovarian cancer17èmes Journées du Cancéropôle Grand Sud-Ouest, Cancéropôle Grand Sud-Ouest (GSO), Nov 2021, Carcassonne, France
Conference papers
hal-03440770v1
|
|
Detection of the ovarian cancer biomarker in body fluids using nucleic acid aptamers as diagnostic probesEACR Congress 2022 - 28TH Ccongress of the european association for cancer research, Jun 2022, Seville, Spain.
Conference poster
hal-03761537v1
|
|
Effects of quercetin on the viability of MDA-MB-231 breast cancer cells7th Pharmacy and Medical Biochemistry Student's Symposium "FARMEBS", Jun 2018, Zagreb, Croatia
Conference poster
hal-02355335v1
|
|
Développement d'aptamères pour la détection de biomarqueurs de cancers ovariens dans les urinesBiochimie, Biologie Moléculaire. Université de Nîmes, 2023. Français. ⟨NNT : 2023NIME0003⟩
Theses
tel-04198869v1
|